|
Pisters R., Lane D.A., Marin F., Camm A.J., Lip G.Y.H. Stroke and Thromboembolism in Atrial Fibrillation - Systematic Review of Stroke Risk Factors and Risk Stratification Schema -. Circulation Journal. 2012. 76:2289-2304. 10.1253/circj.CJ-12-1036
AÑO: 2012; IF: 3.578
|
23001018
|
Ruiz-Nodar JM, Marín F, Manzano-Fernández S, Valencia-Martín J, Hurtado JA, Roldán V, Pineda J, Pinar E, Sogorb F, Valdés M, Lip GY. An evaluation of the CHADS? stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularization. Chest. 2011 Jun;139(6):1402-9. doi: 10.1378/chest.10-1408. Epub 2010 Sep 23. PubMed PMID: 20864616.
AÑO: 2011; IF: 5.25
|
|
Marín F, Roldán V, Martínez JG, Hernández-Madrid A, Hernández-Romero D, Ortego M, Ibáñez A, Marín-Marín I, Navarro X, Lip GY, Moro C. Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: a pilot study. Thromb Res. 2011 Oct;128(4):391-4. doi: 10.1016/j.thromres.2011.05.022. Epub 2011 Jun 26. PubMed PMID: 21708399.
AÑO: 2011; IF: 2.44
|
|
Banerjee A., Marín F., Lip G.Y.H. A new landscape for stroke prevention in atrial fibrillation: Focus on new anticoagulants, antiarrhythmic drugs, and devices. Stroke. November 2011. 42:3316-3322. 10.1161/STROKEAHA.111.617886
AÑO: 2011; IF: 5.729
|
|
Huber K., Juhani Airaksinen K., Cuisset T., Marín F., Rubboli A., Lip G.Y.H. Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Similarities and dissimilarities between north America and Europe. Thrombosis and Haemostasis. October 2011. 106:569-571. 10.1160/TH11-08-0602
AÑO: 2011; IF: 5.044
|